This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock Z, Kantarjian HM . The biology of chronic myeloid leukemia. N Engl J Med 1999; 341: 164–172.
Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA . Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 1981; 58: 158–163.
Raskind WH, Ferraris AM, Najfeld V, Jacobson RJ, Moohr JW, Fialkow PJ . Further evidence for the existence of a clonal Ph-negative stage in some cases of Ph-positive chronic myelocytic leukemia. Leukemia 1993; 7: 1163–1167.
Kaye FJ, Najfeld V, Singer J, Cuttner J, Fialkow PJ . Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemia. Am J Hematol 1984; 17: 93–96.
Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830.
Kelliher MA, Mc Laughlin J, Witte ON, Rosenberg N . Induction of a chronic myelogenous leukemia like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 1990; 87: 6649–6653.
Buchdunger E, Zimmermann J, Mett H, Meyer T, Muller M, Druker BJ et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res 1996; 56: 100–104.
Capdeville R, Buchdunger E, Zimmermann J, Matter A . Glivex (STI571, Imatinib), a rationally developed, targeted anticancer drug. Nat Rev 2002; 1: 493–502.
Fleischman EW, Reshmi S, Frenkel MA . MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia. Genes Chromosomes Cancer 1999; 24: 151–155.
de la Chapelle A, Knuutila S, Elonen, E . Translocation (2;11)(p21;q23) in acute non-lymphocytic leukaemia: a non-random association. Scand J Haematol 1986; 45 (Suppl): 91–97.
Braziel RM, Launder TM, Druker BJ, Olson SB, Magenis R, Mauro MJ et al. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience. Blood 2002; 100: 435–441.
Andersen MK, Pedersen-Bjergaard J, Kjeldsen L, Dufva IH, Brondum-Nielsen K . Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia 2002; 16: 1390–1395.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Royer-Pokora, B., Hildebrandt, B., Redmann, A. et al. Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment. Leukemia 17, 807–810 (2003). https://doi.org/10.1038/sj.leu.2402877
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402877